Galenica Working With Centerview on M&A Plans, Separating Vifor

  • Centerview has been advising Swiss company for 10 years
  • Galenica is seeking assets for Vifor in Switzerland, Europe

Galenica AG is working with investment bank Centerview Partners on potential acquisitions as well as plans to split up the Swiss company and sell shares in its pharmaceutical unit Vifor.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.